GLP-3 RETA 60mg
Maximum strength triple agonist peptide for high-intensity metabolic research.
Retatrutide 60mg represents the highest concentration available in this series, designed for advanced research environments requiring strong metabolic pathway activation. Its ability to interact with GLP-1, GIP, and glucagon receptors simultaneously allows for deep analysis of metabolic systems and energy regulation. This high-potency version is commonly used in research focused on multi-system metabolic interaction, where stronger receptor engagement is necessary to observe meaningful outcomes. Due to its strength, it is best suited for experienced research settings where precision and controlled experimentation are critical. For research use only. Not for human consumption.
Accepted payments